TNFSF10 and melanoma: Of note, regardless of the expression levels of TRAIL, the treatment with anti-TRAIL neutralizing Ab, but not control Ab, partly but significantly abrogated the inhibitory effect on tumor growth of combined IL-27 and poly(I:C) in all three melanoma cell lines (Fig. 4D).